Sorry, you need to enable JavaScript to visit this website.

Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.

McDiarmid et al. 2021. Manchester Intermittent versus Daily Diet App Study (MIDDAS): A pilot randomized controlled trial in patients with type 2 diabetes

Nestle Health Science

This pilot randomised control trial tests the feasibility and potential efficacy of remotely supported intermittent low-energy diets (ILEDs) and continuous low-energy diets (CLEDs) in people with type 2 diabetes (T2D). The study demonstrated feasibility and efficacy for remote ILEDs and CLEDs for weight loss and HbA1c reduction.